Marks start of European commercial rollout of aXess™, bringing it into routine clinical practiceBuilds on CE mark approval in record time, underpinned by positive EU pivotal trial dataIntroduces a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results